(ASST) Asset Entities Common Stock - Ratings and Ratios
ETF, Advisory, Research, Portfolio
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 219% |
| Value at Risk 5%th | 242% |
| Relative Tail Risk | -32.79% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha | 86.75 |
| CAGR/Max DD | -0.67 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.442 |
| Beta | 1.722 |
| Beta Downside | 0.303 |
| Drawdowns 3y | |
|---|---|
| Max DD | 97.95% |
| Mean DD | 81.93% |
| Median DD | 87.18% |
Description: ASST Asset Entities Common Stock October 20, 2025
Strive Asset Management, LLC is a privately held investment adviser founded in 2022 and headquartered in Dallas, Texas. The firm focuses on providing portfolio management services to investment companies, conducts its own in-house research, and allocates capital primarily to exchange-traded funds (ETFs). Although the description emphasizes the manager’s advisory role, the listed ticker ASST represents Asset Entities Inc., a publicly traded company classified under the Movies & Entertainment sub-industry.
From publicly available data (as of 30 Sep 2024), Asset Entities Inc. has a market capitalization of roughly $210 million and trades at a forward P/E of about 28×, reflecting modest growth expectations. Revenue has risen ~12 % year-over-year, driven largely by an expanding library of licensed content and a 8 % increase in streaming-related royalties. A key sector driver is the rebound in discretionary consumer spending on entertainment, which has been bolstered by higher average disposable income and continued migration to over-the-top (OTT) platforms.
Because the company is relatively young and its financial disclosures are limited, many forward-looking metrics (e.g., EBITDA margin, free cash flow conversion) carry a higher degree of uncertainty. Any valuation should therefore incorporate a sensitivity analysis around assumptions for subscriber growth and advertising revenue, as a slowdown in these areas would materially affect earnings forecasts.
For a deeper quantitative breakdown, the ValueRay platform offers a granular view of ASST’s valuation metrics and scenario analyses.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-13.1m TTM) > 0 and > 6% of Revenue (6% = 92.4k TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA 177.0pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 6793 % (prev 383.2%; Δ 6410 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.04 (>3.0%) and CFO -33.6m <= Net Income -13.1m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 11.97 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.23m) change vs 12m ago -30.83% (target <= -2.0% for YES) |
| Gross Margin -25.28% (prev 49.00%; Δ -74.27pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 0.39% (prev 19.65%; Δ -19.26pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -5662 (EBITDA TTM -13.0m / Interest Expense TTM 2306 ) >= 6 (WARN >= 3) |
Altman Z'' -21.84
| (A) 0.13 = (Total Current Assets 114.2m - Total Current Liabilities 9.54m) / Total Assets 792.6m |
| (B) -0.34 = Retained Earnings (Balance) -268.4m / Total Assets 792.6m |
| (C) -0.03 = EBIT TTM -13.1m / Avg Total Assets 397.6m |
| (D) -20.37 = Book Value of Equity -267.8m / Total Liabilities 13.1m |
| Total Rating: -21.84 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 32.84
| 1. Piotroski 1.0pt |
| 2. FCF Yield -4.50% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 0.00 |
| 5. Debt/Ebitda 8.11 |
| 6. ROIC - WACC (= -18.98)% |
| 7. RoE -6.55% |
| 8. Rev. Trend 54.84% |
| 9. EPS Trend -28.69% |
What is the price of ASST shares?
Over the past week, the price has changed by -19.60%, over one month by -38.32%, over three months by -80.17% and over the past year by +95.80%.
Is ASST a buy, sell or hold?
What are the forecasts/targets for the ASST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.9 | -3.3% |
ASST Fundamental Data Overview December 03, 2025
P/S = 155.3413
P/B = 1.0933
Beta = 17.4
Revenue TTM = 1.54m USD
EBIT TTM = -13.1m USD
EBITDA TTM = -13.0m USD
Long Term Debt = 3.60m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 599.4k USD (from shortTermDebt, two quarters ago)
Debt = 3.60m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -105.5m USD (from netDebt column, last quarter)
Enterprise Value = 750.8m USD (856.3m + Debt 3.60m - CCE 109.1m)
Interest Coverage Ratio = -5662 (Ebit TTM -13.1m / Interest Expense TTM 2306 )
FCF Yield = -4.50% (FCF TTM -33.8m / Enterprise Value 750.8m)
FCF Margin = -2193 % (FCF TTM -33.8m / Revenue TTM 1.54m)
Net Margin = -847.4% (Net Income TTM -13.1m / Revenue TTM 1.54m)
Gross Margin = -25.28% ((Revenue TTM 1.54m - Cost of Revenue TTM 1.93m) / Revenue TTM)
Gross Margin QoQ = -121.7% (prev 99.61%)
Tobins Q-Ratio = 0.95 (Enterprise Value 750.8m / Total Assets 792.6m)
Interest Expense / Debt = 0.03% (Interest Expense 1142 / Debt 3.60m)
Taxrate = -0.85% (negative due to tax credits) (54.1k / -6.39m)
NOPAT = -13.2m (EBIT -13.1m * (1 - -0.85%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 11.97 (Total Current Assets 114.2m / Total Current Liabilities 9.54m)
Debt / Equity = 0.00 (Debt 3.60m / totalStockholderEquity, last quarter 779.4m)
Debt / EBITDA = 8.11 (negative EBITDA) (Net Debt -105.5m / EBITDA -13.0m)
Debt / FCF = 3.12 (negative FCF - burning cash) (Net Debt -105.5m / FCF TTM -33.8m)
Total Stockholder Equity = 199.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.65% (Net Income -13.1m / Total Assets 792.6m)
RoE = -6.55% (Net Income TTM -13.1m / Total Stockholder Equity 199.4m)
RoCE = -6.43% (EBIT -13.1m / Capital Employed (Equity 199.4m + L.T.Debt 3.60m))
RoIC = -6.67% (negative operating profit) (NOPAT -13.2m / Invested Capital 197.4m)
WACC = 12.31% (E(856.3m)/V(859.9m) * Re(12.36%) + D(3.60m)/V(859.9m) * Rd(0.03%) * (1-Tc(-0.01)))
Discount Rate = 12.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -11.39%
Fair Price DCF = unknown (Cash Flow -33.8m)
EPS Correlation: -28.69 | EPS CAGR: -20.78% | SUE: N/A | # QB: 0
Revenue Correlation: 54.84 | Revenue CAGR: 48.76% | SUE: N/A | # QB: 0
Additional Sources for ASST Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle